New infection rates are declining, but HIV still remains a serious health problem in the U.S

By the end of 2016, 36.7 million people were living with HIV/AIDS globally. Africa remains the most affected region, accounting for 70% of the total number of infected individuals.

In the U.S., the number of annual HIV infections declined by 18% from 2008 to 2014. However, HIV/AIDS remains a healthcare problem. According to the Centers for Disease Control and Prevention (CDC), targeted HIV prevention efforts might be the reason for the decline in HIV infection and diagnosis rates.

Current U.S. HIV/AIDS statistics

  • More than 1.1 million people are living with HIV
  • 1 in 7 Americans with HIV are not aware that they are HIV positive
  • In 2014, an estimated 37,600 new HIV infections were reported
  • In 2014, approximately 50% of new HIV infections were in the South
  • In 2015, approximately 18,300 people were diagnosed with AIDS

HealthTap_HIV_test.jpg

The current and future HIV/AIDS health care goals

In July 2010, the White House released the National HIV/AIDS Strategy (NHAS) and the federal HIV Care Continuum Initiative. Efforts are focused on increasing HIV testing, care, and treatment in the U.S. NHAS strives to achieve these new goals by 2020:

  1. Reduce the number of new HIV infections
  2. Increase access to care and improve health outcomes for people living with HIV
  3. Reduce HIV-related disparities and health inequities
  4. Achieve a more coordinated national response

In order to the achieve these goals by 2020, NHAS necessitates these healthcare interventions:

  • Widespread HIV screening and testing for adolescents, adults, and pregnant women in healthcare settings
  • Early access to healthcare and antiretroviral therapy (ART)
  • Increased engagement and support for people living with HIV
  • Universal viral suppression to reduce transmission of the virus
  • Full access to comprehensive pre-exposure prophylaxis (PrEP) services
  • Treatment adherence monitoring

The CDC strives to improve the outcomes at every stage of the HIV Care Continuum through the following initiatives:

  • Increase funding for HIV testing at health departments and community-based organizations (CBOs)
  • Increase technical assistance to implement effective HIV prevention programs at health departments and CBOs
  • Improve surveillance and technology to assess care continuum
  • Develop guidelines on HIV testing, care, treatment, and prevention for providers
  • Launch educational campaigns

Are there enough healthcare providers to support the National HIV/AIDS Strategy goals?

Due to advancements in ART, HIV has become a manageable chronic disease. The life expectancy of HIV-infected individuals is almost the same as non-infected individuals. The new challenge is whether these patients will be managed by generalists or HIV specialists. Most patients seek care with a primary care provider (PCP) or a HIV specialist.

Currently, the demand for demand for physicians is growing faster than supply in the U.S. healthcare system. Projections for 2025 show a total physician shortfall between 61,700 and 94,700. The projected shortfall in primary care ranges between 14,900 and 35,600 PCPs in 2025. Many medical school programs are incorporating HIV care training for PCPs to increase the number of providers who can adequately provide both HIV and primary care.

HealthTap_digital_care.jpg

Healthcare technology is bridging the provider-patient gap

Telemedicine is one strategy for addressing the shortfall of physicians relative to demand. With email, telephone, and video consultations, PCPs can expand the scope of their practice and complete specialty consultation remotely. For HIV/AIDS patients, telemedicine can be used to:

  • Link patients directly to specialty healthcare providers
  • Facilitate consultations between PCPs and infectious disease specialists, and
  • Deliver continuing medical education

Today many HIV/AIDS telemedicine based programs have been successfully implemented. Here are some examples:

There are many benefits of telemedicine based care for patients and providers

Several studies have shown improved patient satisfaction with telemedicine HIV based care due to:

  • Reduced time and costs related to travel
  • Less time off work
  • Shorter wait times to see a PCP or HIV specialist
  • Reduced HIV-related stigma because patients don’t have to receive treatment in a HIV clinic

In turn, healthcare providers, especially PCPs enjoy the following benefits from increased technology in HIV/AIDS management:

  • Improved multidisciplinary communication
  • Continued education through webinars and conference calls
  • Improved decision making and reduced referrals
  • Increased patient appointments and improved monitoring of treatment compliance
  • Improved communication between urban institutions and rural clinics

Continued education and support for PCPs are critical to improve provider confidence and expand the scope of their practice. Telemedicine can help consolidate primary care in HIV/AIDS management. This may ultimately lead to fewer gaps in care, decreased specialist costs, and increased access to services for patients living with HIV/AIDS.

At HealthTap, we continue to make strides to improve healthcare delivery. You can join virtual care movement and use HealthTap to expand the scope of your practice.  Click the button below to start your application.

Sign Up Today

Like this article and want more? Read about how Virtual Care can Reduce Waste in Healthcare

mm

Simitha Singh Rambiritch

Simitha Singh Rambiritch is a Dentist from South Africa with a Masters in Science in Oral Medicine and Periodontology from the University of the Witwatersrand (Wits). She was a clinician in the South African public and private sector and an oral medicine and periodontology lecturer for dental and oral hygiene students at the Wits School of Oral Health Sciences for almost 8 years. She also authored several publications in the South African Dental Journal. Simitha was the 2013 recipient of the Margot Lachmann Fellowship, for excellence in cancer research, with a focus on early diagnostic biomarkers in premalignant and autoimmune conditions and their conversion rate to oral cancer. She was invited to present her findings at the 9th International Congress on Autoimmunity in Nice, France.

Leave a Reply

Your email address will not be published. Required fields are marked *